Here are some hints from the lawsuit: 65. Spec
Post# of 148183
Quote:
65. Specifically, on June 20, 2019, the CEO, who has no medical training, demanded that the clinical trial office at Amarex Clinical Research LLC (“Amarex”) “submit the IND and protocol that you had made for colon cancer for submission to the FDA by tomorrow”
Quote:
The CEO, in his July 1 Email, represented to the Board that Dr. Pestell had failed
to “work with the CEO to expedite the TNBC trial,' ignored the CEO’s “constant request(s)” relating to the trial, and been uncooperative with regard to the trial.
RP saying here it should have taken longer, though publicly had said something different.
Quote:
Dr. Pestell and his team worked tirelessly to prepare the TNBC trial, such that it
was ready to start accruing patients within 9 months. In the words of Dr. Massimo Cristofanilli, the principal investigator of the TNBC trial, being ready to accrue patients “just 9 months” after initiating the trial, was “a remarkable achievement in Oncology!”